Little is yet known about the genetics of this potentially manageable childhood condition, which is characterised by regurgitation of urine from the bladder to the kidney. The VUR phenotype is associated with shortness of the submucosal segment of the ureter due to congenital lateral ectopia of the ureteric orifice. VUR is found in 30-50% of infants and young children with a urinary tract infection. A serious concern in families with an affected patient is that approximately one half of siblings or offspring will be affected, but up to a half of these affected siblings and offspring may be asymptomatic in childhood. If left untreated, these patients may present later in life with proteinuria, hypertension or renal failure. VUR is the commonest cause of end-stage renal failure in children, and an important cause in adults. As the kidney damage resulting from severe VUR is preventable, early detection is desirable. The techniques for clinical diagnosis are invasive and costly, reinforcing the importance of identification of a gene for VUR to facilitate genetic screening. Although family studies suggest a major dominant gene, the inheritance pattern is still a matter of debate. In rare instances, VUR occurs in association with other diseases, such as the coloboma-ureteric-renal syndrome, which is caused by a PAX2 gene mutation. In this review, we present evidence that this common disorder may be caused by mutations in the developmental pathway of which the PAX2 gene forms a part.
INTRODUCTION
Primary vesicoureteric reflux (VUR) (OMIM # 193000) is a common disorder in children, and shows a strong familial association (1) (2) (3) (4) (5) (6) (7) (8) (9) . VUR is the regurgitation of urine from the bladder into the ureter and kidney (10) . The true incidence of VUR in an unselected population has not been established, although current estimates suggest it is between 1/100 and 1/1000 (11, 12) . This may be compared with autosomal dominant polycystic kidney disease (ADPKD) which, at a frequency of 1/1000 in the population, is considered to be one of the commonest dominant genetic diseases of man (13) .
It is clear that in a large proportion of patients VUR is genetic in origin. Forty five percent of children with primary VUR are from families where at least one additional family member is affected, and often the disease occurs in two or more generations (10, 14) . In addition, there have been several documented instances in identical twins and triplets (reviewed in 15) .
Approximately one-third of individuals with VUR have some degree of renal parenchymal damage, termed reflux nephropathy (16) . Reflux nephropathy, like ADPKD, is an important cause of end-stage renal failure (17) .
THE NATURE OF VUR
VUR is the regurgitation of urine through a vesicoureteric junction which is either incompetent, immature or abnormally placed (18) . The defect, which is one of length, diameter, musculature and/or innervation of the submucosal segment of ureter, usually involves a shortening of the submucosal ureteric segment due to congenital lateral ectopia of the ureteric orifice (shown in Fig. 1 ) (19) (20) (21) (22) (23) (24) . It could be envisaged that this anomaly may be caused by mutations in one or several developmental genes.
With increasing age, the intravesical segment of the ureter elongates, which increases the ratio between the submucosal tube length and ureteric diameter (25) . The end result is that VUR may resolve spontaneously in many children. Renal scarring, however, is permanent.
VUR varies in degree, and is best divided into five grades using the classification proposed by the International Reflux Study in children (26) (Fig. 2) . Grades III-V VUR are all associated with increasing degrees of dilatation of the collecting system.
CLINICAL FEATURES OF REFLUX NEPHROPATHY
Reflux nephropathy, which may be complicated by hypertension, proteinuria or renal failure (27) , usually occurs before 18 months of age (28, 29) , and frequently is not detected until investigation following a urinary tract infection. In Australia and New Zealand, 25% of children <16 years of age who entered renal replacement programmes had reflux nephropathy (17) . In adult Caucasians <50 years of age, 5-15% of cases of end-stage renal disease were due to reflux nephropathy (30) . Interestingly, VUR is much less *To whom correspondence should be addressed prevalent in Afro-American populations (31) . Reflux nephropathy and its associated complications should be preventable by identifying and treating all children with VUR (17).
VUR IN SIBLINGS AND OFFSPRING
Thirty four to forty five percent of an affected patient's siblings will have reflux between birth and 18 months of age (14, 32, 33) . The severity of VUR in siblings does not correlate with the grade of reflux in the index patient (32) . VUR also appears to be more frequent in female siblings (5), although the reason for this is not known.
In terms of identifying which siblings or offspring of an affected patient to screen for VUR, there are no simple clinical or laboratory parameters available at present, and a current strategy is to screen all siblings or offspring. A major goal of antenatal and postnatal screening of siblings and offspring is to identify those children who may be at risk of reflux nephropathy, because with early detection the incidence of renal damage in siblings may be reduced compared with index patients (7).
ASSOCIATION OF VUR WITH OTHER CONDITIONS
VUR may occur in association with other conditions, such as a bifid or duplex pelvicalyceal collecting system or ureter (34) , pelviureteric junction obstruction (35) , nocturnal enuresis (36), detrusor instability or detrusor-sphincter dyssynergia (37), hypospadias and undescended testicles (38) . VUR has also been observed in association with several syndromes, notably Hirschsprung's disease (R.R.B., unpublished), prune-belly syndrome (39, 40) , a syndrome of ectrodactyly, ectodermal dysplasia and cleft lip/palate (41), coloboma-ureteral-renal syndrome (42) and Robinow dwarfism (43) . In addition, chromosomal abnormalities of the short arms of chromosomes 8 or 10 have been reported in two studies where VUR was associated with developmental disabilities, skeletal anomalies, hypotonia, rectal atresia, horseshoe kidney and malrotation of the intestine (44) , and multicystic kidney, hearing loss, heart defects, growth retardation and psychomotor delay (45), respectively.
POTENTIAL PROBLEMS ASSOCIATED WITH DETERMINATION OF THE GENETICS OF VUR
A gene responsible for VUR may, in theory, be identified by linkage analysis in affected pedigrees, and candidate genes may also be screened by mutational analysis in affected individuals. Since VUR may be genetically heterogeneous, linkage analysis would ideally be done on a single, large affected pedigree. The greatest problem with such an analysis is the determination of the disease status of an individual. VUR, particularly when of a mild degree, may resolve spontaneously by puberty (25) . In this setting there will be no signs that an asymptomatic adult had VUR in childhood, as the kidneys would be normal, and VUR would therefore appear incompletely penetrant (4, 7, 12, 15, 38, 46, 47) . The only way of absolutely determining the clinical status of an individual is by screening that individual in infancy using micturating cystourethrography. Unfortunately, this test is invasive, time consuming and unpleasant, and adult members of a pedigree are unlikely to have been screened in infancy. It follows therefore that disease-free individuals cannot necessarily be classified in the linkage study as unaffected.
Several studies have concluded that VUR is caused by a major dominantly inherited allele (4, 12, 15) , while others have suggested that VUR is a multifactorial, or polygenic trait (6, 8, 48, 49) . Despite conflicting views on the inheritance pattern, the strong familial association of VUR has prompted several linkage studies, which produced weak evidence for association of the VUR gene with several histocompatibility (HLA) antigens or haplotypes. These were HLA-B12 (50,51), HLA-B15 (51), HLA-AW32 (52,53), HLA-A3 (54), HLA-A9 and haplotypes A9-B12 and A2-B8 (15). Another study described a family with a possible X-linked recessive pattern of inheritance (55) .
A recent prospective study of the transmission of VUR to the offspring of a parent with known VUR, using micturating cystourethrography, showed that 24/36 offspring (66%) exhibited VUR (9) . The same authors reviewed the literature, revealing a 65% rate of reflux in the offspring of known affected patients (9) . Although these results were obtained from a pre-selected group of patients, and the degree of genetic heterogeneity, if any, could not be estimated, the high rate of transmission favours autosomal dominant inheritance with 100% penetrance. The alternative, that VUR is a multifactorial trait, cannot be excluded, but at least one study, described below, suggests that VUR is not likely to be a polygenic disease.
That VUR is polygenic is rendered unlikely by the finding that in one family, where VUR occurred as part of a syndrome, the disease was associated with mutation of the PAX2 gene (56) . We have identified frameshift mutations in exons 2 and 5 of PAX2 in several patients with coloboma-ureteric-renal syndrome, which involved VUR as part of the phenotype (56,57, M.R.E., unpublished). These results suggest that mutation of a single gene, such as PAX2 or similar genes, could be sufficient to cause primary VUR.
ANALYSIS OF PAX2 AS A CANDIDATE GENE FOR VUR
The primary defect in VUR is thought to arise during embryogenesis of the urinary tract. It has been suggested that the timing and position of branching of the ureteric bud from the Wolffian duct is related linearly to where the ureteric orifice opens in the bladder wall; the sooner the branching occurs, the more lateral the orifice will be in the bladder (58) . Abnormalities in the ureteric bud, which induces differentiation of the nephrogenic mesenchyme, could also be responsible for abnormal development, or dysgenesis of the collecting ducts or renal papillae, associated with intrarenal reflux (59, 60) . PAX2 is a good candidate gene for mutations associated with developmental abnormalities of the ureteric bud and kidney. During development of the urinary tract, PAX2 is expressed in the ureteric bud and in the differentiating nephrogenic mesenchyme (61, 62) . PAX2 is a member of the paired-box family of genes (63), and plays a critical role in the development of both the kidney and ureteric bud (56, 64) . The Krd mutant mouse, in which an allele of the PAX2 gene is deleted, has ureteric dilatation as part of its phenotype (64) .
To test the possibility that a PAX2 mutation may cause primary VUR, we analysed the PAX2 gene in eight unrelated pedigrees with VUR, shown in Figure 3 . The only clinical problem presenting in the families was VUR and/or reflux nephropathy. Exons 2-12 of the PAX2 gene were examined by single-stranded conformational polymorphism (SSCP) analysis in 23 clinically affected and 34 disease-free individuals from the eight families. No SSCP polymorphisms were detected in PAX2, suggesting that PAX2 was not mutated in any of these patients. Three markers near the PAX2 gene, including a dinucleotide repeat in intron 8 of PAX2, were also used for linkage analysis, but linkage could not be established. In a separate study, linkage to PAX2 was excluded in a three generation pedigree involving four individuals with VUR, and one with hypospadias (R.F. Gagel, pers. comm.).
While PAX2 is a promising candidate as a major gene for VUR, these studies have suggested that PAX2 may not be involved in the aetiology of primary VUR. The association of PAX2 mutation in coloboma-ureteric-renal syndrome (56, 57) suggested that the expression of PAX2 may be part of a developmental pathway disrupted in VUR. Other candidate genes, such as c-ret and N-myc, are being tested for involvement in VUR using strategies similar to the above. Linkage studies are also under way to localise the VUR gene.
SUMMARY AND FUTURE DIRECTIONS
We have tried to convey in this review that VUR is a common, clearly genetic, but relatively poorly understood disorder genetically. While several studies (12, 15, 56) refute the suggestion that VUR is a polygenic disease, a gene for familial primary VUR remains elusive. Meanwhile, there is a real need to identify children who have VUR prior to the development of reflux nephropathy. It is a tragedy that VUR causes as much end-stage renal failure as the commonest dominant genetic disease known to man, i.e. ADPKD, but all patients with VUR could quite effectively be treated if the affected individuals could all be identified. Identification of individuals with VUR may well be able to prevent all VUR-induced renal failure. Unfortunately, many individuals with VUR are asymptomatic until it is too late.
Ideally the means of identification should be simple, inexpensive and non-invasive. Early diagnosis of VUR is important, as much of the damage to the kidney occurs in the first 2-3 years of life and probably even in utero.
VUR is diagnosed in children by micturating cystourethrography or radionuclide micturating cystography (65) . These methods involve urethral or suprapubic catheterisation, radiographic contrast or radionuclide injection and exposure to radiation. The decision to investigate children using these invasive tests underlies the importance and seriousness of the condition. Ultrasound techniques, on the other hand, are becoming much more sophisticated, but not yet reliable enough to diagnose VUR. The ideal would be to identify infants prior to them developing a urinary tract infection or reflux nephropathy using a genetic screening method. Once identified, infants could then be monitored and treated. Perhaps the greatest immediate application of a genetic test would be the identification of siblings and offspring of an affected patient who are not gene carriers, and who could be spared the anxiety and morbidity associated with medical investigations.
If a gene for VUR was identified, then patients with sporadic VUR could be analysed to determine if their condition was caused by mutations in the same gene as familial VUR. In addition, those at risk of developing renal failure may benefit from an analysis of genotype-phenotype correlations. Such studies would examine the association of certain mutations with reflux grade. Finally, identification of a VUR gene may allow a biochemical understanding of VUR, and possibly the development of new approaches to treatment.
